Canada markets open in 59 minutes

Celcuity Inc. (CELC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
14.37-1.35 (-8.59%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close15.72
Open14.65
Bid0.00 x 1100
Ask0.00 x 900
Day's Range14.21 - 14.78
52 Week Range4.03 - 18.00
Volume404,904
Avg. Volume16,763
Market Cap148.07M
Beta (5Y Monthly)1.22
PE Ratio (TTM)N/A
EPS (TTM)-0.92
Earnings DateMay 05, 2021 - May 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est21.50
  • ACCESSWIRE

    Celcuity Prices Upsized Public Offering of Common Stock

    MINNEAPOLIS, MN / ACCESSWIRE / February 24, 2021 / Celcuity Inc. (NASDAQ:CELC), a clinical stage biotechnology company translating discoveries of new cancer sub-types into 3rd generation diagnostics and expanded therapeutic options for cancer patients, today announced the pricing of its previously announced underwritten public offering of 1,714,000 shares of its common stock at a price to the public of $14.

  • ACCESSWIRE

    Celcuity Announces Proposed Public Offering of Common Stock

    MINNEAPOLIS, MN / ACCESSWIRE / February 22, 2021 / Celcuity Inc. (NASDAQ:CELC), a clinical stage biotechnology company translating discoveries of new cancer sub-types into 3rd generation diagnostics and expanded therapeutic options for cancer patients, today announced that it has commenced an underwritten public offering of $20 million of shares of common stock.

  • ACCESSWIRE

    Celcuity Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights

    Announced a clinical trial collaboration in December with Massachusetts General Hospital, UCLA, and Vanderbilt and Puma Biotechnology to conduct a Phase II clinical trial.In January, announced a clinical trial collaboration with Sarah Cannon .